Skip to main content
Energy and Commerce Committee

Health


Walden: I Thank President Trump for His Continued Commitment to This Fight

11.20.2020

Washington, D.C. – Energy and Commerce Committee Republican Leader Greg Walden (R-OR) released the following statement after President Trump’s speech on the administration’s efforts to lower health care costs.

“During the pandemic, we’ve witnessed first-hand the value of American innovation, and many stakeholders have warned the Most Favored Nation rule would put American innovation and the development of new treatments and cures at risk. I worked closely with President Trump on Right to Try, and I know how much he appreciates the hope that new treatments and cures bring to...

Press Release

E&C GOP Leaders Seek Missing Info on Lab Capacity for Development of COVID-19 Vaccines, Therapeutics, and Diagnostics

11.18.2020

Washington, D.C. - Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Health Subcommittee Republican Leader Dr. Michael Burgess (R-TX) sent a letter to Centers for Disease Control and Prevention (CDC) Director Robert R. Redfield, M.D. to ask the CDC for complete and updated information on domestic BioSafety Level (BSL)-3 and Animal BSL (ABSL)-3 laboratory capacity with the ability to conduct preclinical animal model research for COVID-19 vaccines, therapeutics, and diagnostics development.

Ranging from BSL-1 to BSL-4, with BSL-4 posing...

Press Release

Letter to CDC to Seek Missing Info on Lab Capacity for Development of COVID-19 Vaccines, Therapeutics, and Diagnostics

11.18.2020

Excerpt: “The lack of information on BSL-3 laboratory capacity is of concern because it may be contributing to delays and bottlenecks in preclinical COVID-19 research. Although the BSL-3 laboratory capacity is not fully known, the extraordinary demand for COVID-19 preclinical research may have overwhelmed the known, available capacity,” wrote Walden, Guthrie, and Burgess.

Click HERE to read the letter to the CDC.

Letter

Health

Jurisdiction


The health sector broadly, including private and public health insurance (Patient Protection and Affordable Care Act, Medicare, Medicaid, CHIP); biomedical research and development; hospital construction; mental health; health information technology, privacy, and cybersecurity; medical malpractice and medical malpractice insurance; the 340B drug discount program; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.